Third, it is also possible that JACLS ALL02 HR cohort might not include BCP-ALL cases with BCR-ABL like gene expression signature, in which JAK2 activating mutation and CRLF2 genomic aberration are concurrently present with IKZF1 deletion. This evidence concerns the gene CRLF2 and acute lymphoblastic leukemia.